Dual-ligand functionalized liposomes with iRGD/trastuzumab co-loaded with gefitinib and lycorine for enhanced metastatic breast cancer therapy
Dilip Kumar Arya
1
,
Prashant Pandey
1
,
Anit Kumar
1
,
Adel Al Fatease
3
,
Giriraj Pandey
4
,
Saurabh Srivastava
4
,
P S Rajinikanth
1, 5
4
Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research
Publication type: Journal Article
Publication date: 2025-02-02
scimago Q2
wos Q1
SJR: 0.619
CiteScore: 7.8
Impact factor: 4.3
ISSN: 08982104, 15322394
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
|
|
|
ACS Applied Bio Materials
1 publication, 12.5%
|
|
|
Bioorganic Chemistry
1 publication, 12.5%
|
|
|
Nanomaterials
1 publication, 12.5%
|
|
|
Journal of Biochemical and Molecular Toxicology
1 publication, 12.5%
|
|
|
Chemical Engineering Journal
1 publication, 12.5%
|
|
|
Discover Oncology
1 publication, 12.5%
|
|
|
Medical Sciences
1 publication, 12.5%
|
|
|
Phytochemistry
1 publication, 12.5%
|
|
|
1
|
Publishers
|
1
2
3
|
|
|
Elsevier
3 publications, 37.5%
|
|
|
MDPI
2 publications, 25%
|
|
|
American Chemical Society (ACS)
1 publication, 12.5%
|
|
|
Wiley
1 publication, 12.5%
|
|
|
Springer Nature
1 publication, 12.5%
|
|
|
1
2
3
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
8
Total citations:
8
Citations from 2024:
8
(100%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Arya D. K. et al. Dual-ligand functionalized liposomes with iRGD/trastuzumab co-loaded with gefitinib and lycorine for enhanced metastatic breast cancer therapy // Journal of Liposome Research. 2025. Vol. 35. No. 2. pp. 173-187.
GOST all authors (up to 50)
Copy
Arya D. K., Pandey P., Kumar A., Chidambaram K., Fatease A. A., Pandey G., Srivastava S., Rajinikanth P. S. Dual-ligand functionalized liposomes with iRGD/trastuzumab co-loaded with gefitinib and lycorine for enhanced metastatic breast cancer therapy // Journal of Liposome Research. 2025. Vol. 35. No. 2. pp. 173-187.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1080/08982104.2025.2457453
UR - https://www.tandfonline.com/doi/full/10.1080/08982104.2025.2457453
TI - Dual-ligand functionalized liposomes with iRGD/trastuzumab co-loaded with gefitinib and lycorine for enhanced metastatic breast cancer therapy
T2 - Journal of Liposome Research
AU - Arya, Dilip Kumar
AU - Pandey, Prashant
AU - Kumar, Anit
AU - Chidambaram, Kumarappan
AU - Fatease, Adel Al
AU - Pandey, Giriraj
AU - Srivastava, Saurabh
AU - Rajinikanth, P S
PY - 2025
DA - 2025/02/02
PB - Taylor & Francis
SP - 173-187
IS - 2
VL - 35
SN - 0898-2104
SN - 1532-2394
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2025_Arya,
author = {Dilip Kumar Arya and Prashant Pandey and Anit Kumar and Kumarappan Chidambaram and Adel Al Fatease and Giriraj Pandey and Saurabh Srivastava and P S Rajinikanth},
title = {Dual-ligand functionalized liposomes with iRGD/trastuzumab co-loaded with gefitinib and lycorine for enhanced metastatic breast cancer therapy},
journal = {Journal of Liposome Research},
year = {2025},
volume = {35},
publisher = {Taylor & Francis},
month = {feb},
url = {https://www.tandfonline.com/doi/full/10.1080/08982104.2025.2457453},
number = {2},
pages = {173--187},
doi = {10.1080/08982104.2025.2457453}
}
Cite this
MLA
Copy
Arya, Dilip Kumar, et al. “Dual-ligand functionalized liposomes with iRGD/trastuzumab co-loaded with gefitinib and lycorine for enhanced metastatic breast cancer therapy.” Journal of Liposome Research, vol. 35, no. 2, Feb. 2025, pp. 173-187. https://www.tandfonline.com/doi/full/10.1080/08982104.2025.2457453.
Profiles